Health & Life Co., Ltd. (TPEX:1781)
Taiwan
· Delayed Price · Currency is TWD 11.00
-0.10 (-0.90%)
Apr 29, 2026, 12:49 PM CST
Health & Life Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 398.05 | 706.39 | 601.17 | 797.54 | 811.88 | Upgrade
|
| Revenue Growth (YoY) | -43.65% | 17.50% | -24.62% | -1.77% | 4.87% | Upgrade
|
| Cost of Revenue | 327.93 | 558.65 | 508.07 | 699.82 | 766.12 | Upgrade
|
| Gross Profit | 70.12 | 147.74 | 93.11 | 97.73 | 45.76 | Upgrade
|
| Selling, General & Admin | 113.59 | 126.88 | 116.95 | 125.47 | 119.84 | Upgrade
|
| Research & Development | 19.94 | 18.35 | 16.16 | 17.34 | 22.81 | Upgrade
|
| Operating Expenses | 133.52 | 145.24 | 134.17 | 142.11 | 142.65 | Upgrade
|
| Operating Income | -63.41 | 2.5 | -41.06 | -44.39 | -96.89 | Upgrade
|
| Interest Expense | -5.98 | -3.38 | -5.27 | -3.14 | -3.08 | Upgrade
|
| Interest & Investment Income | 4.79 | 2.43 | 2.26 | 0.78 | 1.95 | Upgrade
|
| Currency Exchange Gain (Loss) | -7.78 | 19.15 | 3.91 | 22.79 | 24.28 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.34 | 7.65 | 2.6 | 6.96 | -7.56 | Upgrade
|
| EBT Excluding Unusual Items | -67.03 | 28.35 | -37.57 | -17 | -81.3 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.32 | -0.02 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.06 | 0.01 | 1.45 | - | Upgrade
|
| Legal Settlements | - | - | - | - | -2 | Upgrade
|
| Other Unusual Items | - | 0.39 | - | 0.09 | - | Upgrade
|
| Pretax Income | -67.35 | 28.78 | -37.56 | -15.47 | -83.3 | Upgrade
|
| Income Tax Expense | -5.69 | 4.54 | -4.33 | 2.08 | -20.96 | Upgrade
|
| Net Income | -61.67 | 24.24 | -33.23 | -17.55 | -62.34 | Upgrade
|
| Net Income to Common | -61.67 | 24.24 | -33.23 | -17.55 | -62.34 | Upgrade
|
| Shares Outstanding (Basic) | 47 | 47 | 47 | 47 | 47 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 50 | 47 | 47 | 47 | Upgrade
|
| Shares Change (YoY) | -5.96% | 6.34% | - | - | -0.21% | Upgrade
|
| EPS (Basic) | -1.30 | 0.51 | -0.70 | -0.37 | -1.31 | Upgrade
|
| EPS (Diluted) | -1.30 | 0.48 | -0.70 | -0.37 | -1.31 | Upgrade
|
| Free Cash Flow | -3.74 | 30.65 | 76.94 | -85.44 | -143.53 | Upgrade
|
| Free Cash Flow Per Share | -0.08 | 0.61 | 1.62 | -1.80 | -3.03 | Upgrade
|
| Gross Margin | 17.61% | 20.91% | 15.49% | 12.25% | 5.64% | Upgrade
|
| Operating Margin | -15.93% | 0.35% | -6.83% | -5.56% | -11.93% | Upgrade
|
| Profit Margin | -15.49% | 3.43% | -5.53% | -2.20% | -7.68% | Upgrade
|
| Free Cash Flow Margin | -0.94% | 4.34% | 12.80% | -10.71% | -17.68% | Upgrade
|
| EBITDA | -52.94 | 14.5 | -29.21 | -34.51 | -89.91 | Upgrade
|
| EBITDA Margin | -13.30% | 2.05% | -4.86% | -4.33% | -11.07% | Upgrade
|
| D&A For EBITDA | 10.46 | 12.01 | 11.85 | 9.87 | 6.98 | Upgrade
|
| EBIT | -63.41 | 2.5 | -41.06 | -44.39 | -96.89 | Upgrade
|
| EBIT Margin | -15.93% | 0.35% | -6.83% | -5.56% | -11.93% | Upgrade
|
| Effective Tax Rate | - | 15.77% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.